These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 392738)

  • 1. In vitro enhancement of natural cytotoxicity by tumour necrosis serum.
    Pasanen VJ
    Scand J Immunol; 1979; 10(3):281-4. PubMed ID: 392738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
    Kearney R; Harrop P
    Br J Cancer; 1980 Oct; 42(4):559-67. PubMed ID: 7002195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endotoxin-induced serum factor that causes necrosis of tumors.
    Carswell EA; Old LJ; Kassel RL; Green S; Fiore N; Williamson B
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3666-70. PubMed ID: 1103152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic reactivation in vitro of the cytotoxic activity of lymphoid cells from mice bearing syngeneic tumors].
    Schaaf-Lafontaine N
    C R Seances Soc Biol Fil; 1977; 171(3):663-6. PubMed ID: 144008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.
    Warner NL; Woodruff MF; Burton RC
    Int J Cancer; 1977 Jul; 20(1):146-55. PubMed ID: 903182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
    Faraci RP; Schour L
    Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulating influence of bacillus Calmette-Guérin on immunity to polyoma tumors and spontaneous leukemia.
    Lemonde P; Dubreuil R; Guindon A; Lussier G
    J Natl Cancer Inst; 1971 Nov; 47(5):1013-24. PubMed ID: 4330795
    [No Abstract]   [Full Text] [Related]  

  • 13. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation of lymphoid cells with a suppressor effect on the activity of cytotoxic cells in vitro during the growth of a syngeneic mouse tumour.
    Schaaf-Lafontaine N
    Int J Cancer; 1978 Mar; 21(3):329-33. PubMed ID: 631933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.
    Herberman RB; Nunn ME; Holden HT; Staal S; Djeu JY
    Int J Cancer; 1977 Apr; 19(4):555-64. PubMed ID: 844921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
    Shu SY; Chou T; Rosenberg SA
    J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. III. Characterization of the effector cells within RCS that mediate NK lysis.
    Fitzgerald KL; McMaster JS; Ponzio NM
    Int J Cancer; 1981 Nov; 28(5):635-45. PubMed ID: 7030971
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
    Parr IB; Wheeler LE; Alexander P
    Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.
    Hakim AA
    Klin Wochenschr; 1975 Sep; 53(18):881-3. PubMed ID: 1100900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.